Skip to main navigation Skip to search Skip to main content

Description

A Phase II Multi-center Clinical Trials Evaluating Dual Targeting of the PI3K/AKT and NOS Pathways for Treating Metaplastic Breast Cancer (MpBC)

    Fingerprint